• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过大鼠体内几何异构体特异性转运系统对磁共振成像造影剂钆塞酸二钠的胆汁排泄进行定量评估。

Quantitative evaluation of biliary elimination of gadoxetate, a magnetic resonance imaging contrast agent, via geometrical isomer-specific transporting system in rats.

作者信息

Ogawa Junji, Yokota Azusa, Araki Takuya, Aomori Tohru, Nakamura Tomonori, Yamamoto Koujirou, Koshiishi Ichiro

机构信息

Department of Pharmacy, Gunma University Hospital, Gunma, Japan.

出版信息

Biopharm Drug Dispos. 2014 Sep;35(6):362-71. doi: 10.1002/bdd.1907. Epub 2014 Aug 6.

DOI:10.1002/bdd.1907
PMID:24947335
Abstract

Gadoxetate, a magnetic resonance imaging contrast agent, is eliminated into bile. Gadoxetate geometrical isomers are chromatographically classified into two groups by differences between their ionic states (GIs-I and GIs-II; 65:35 w/w); however, the elimination mechanism of each isomer in vivo remains controversial. Thus, the contribution of carrier-mediated transport systems on the biliary elimination of gadoxetate was examined. Gadoxetate was injected intravenously into rats, and the time courses of the plasma concentrations and biliary elimination of GIs-I and GIs-II were examined by high-performance liquid chromatography techniques. The results showed that 34.7% of GIs-I (GIs-I(s); 22.6% of gadoxetate) was quickly eliminated into bile within 30 min after injection. The contents of the residual GIs-I (GIs-I(r)) and GIs-II in plasma similarly decreased according to a first-order elimination process (t1/2=23-27 min), and 64.0% of GIs-I(r) and GIs-II (49.6% of gadoxetate) was eliminated into the bile within 2 h after injection. There was no significant difference between the elimination half-lives of GIs-I(r) and GIs-II in rats. In conclusion, the geometrical isomer with specific conformation corresponding to 22.6% of gadoxetate was eliminated into bile in rats via a carrier-mediated transport system no later than 30 min after intravenous injection.

摘要

钆塞酸二钠是一种磁共振成像造影剂,经胆汁排泄。钆塞酸二钠的几何异构体根据其离子状态的差异通过色谱法分为两组(GIs-I和GIs-II;65:35 w/w);然而,每种异构体在体内的排泄机制仍存在争议。因此,研究了载体介导的转运系统对钆塞酸二钠胆汁排泄的作用。将钆塞酸二钠静脉注射到大鼠体内,通过高效液相色谱技术检测血浆浓度的时间进程以及GIs-I和GIs-II的胆汁排泄情况。结果显示,注射后30分钟内,34.7%的GIs-I(GIs-I(s);占钆塞酸二钠的22.6%)迅速经胆汁排泄。血浆中残留的GIs-I(GIs-I(r))和GIs-II的含量同样按照一级消除过程下降(t1/2 = 23 - 27分钟),注射后2小时内,64.0%的GIs-I(r)和GIs-II(占钆塞酸二钠的49.6%)经胆汁排泄。大鼠体内GIs-I(r)和GIs-II的消除半衰期之间无显著差异。总之,静脉注射后不迟于30分钟,对应22.6%钆塞酸二钠的具有特定构象的几何异构体通过载体介导的转运系统经胆汁排泄到大鼠体内。

相似文献

1
Quantitative evaluation of biliary elimination of gadoxetate, a magnetic resonance imaging contrast agent, via geometrical isomer-specific transporting system in rats.通过大鼠体内几何异构体特异性转运系统对磁共振成像造影剂钆塞酸二钠的胆汁排泄进行定量评估。
Biopharm Drug Dispos. 2014 Sep;35(6):362-71. doi: 10.1002/bdd.1907. Epub 2014 Aug 6.
2
Hepatic uptake of the magnetic resonance imaging contrast agent gadoxetate by the organic anion transporting polypeptide Oatp1.磁共振成像造影剂钆塞酸二钠通过有机阴离子转运多肽Oatp1的肝脏摄取。
J Pharmacol Exp Ther. 1999 Jul;290(1):153-7.
3
Characterization of the intestinal and hepatic uptake/efflux transport of the magnetic resonance imaging contrast agent gadolinium-ethoxylbenzyl-diethylenetriamine-pentaacetic acid.磁性共振成像造影剂钆喷替酸葡甲胺的肠肝摄取/外排转运的特性研究。
Invest Radiol. 2014 Feb;49(2):78-86. doi: 10.1097/RLI.0b013e3182a70043.
4
Gadoxetate disodium in patients with primary sclerosing cholangitis: an analysis of hepatobiliary contrast excretion.钆塞酸二钠用于原发性硬化性胆管炎患者:肝胆对比剂排泄分析
J Magn Reson Imaging. 2014 Jul;40(1):106-12. doi: 10.1002/jmri.24381. Epub 2013 Oct 31.
5
Advanced fibrosis: Correlation between pharmacokinetic parameters at dynamic gadoxetate-enhanced MR imaging and hepatocyte organic anion transporter expression in rat liver.晚期肝纤维化:动态钆塞酸二钠增强磁共振成像的药代动力学参数与大鼠肝脏肝细胞有机阴离子转运体表达的相关性。
Radiology. 2015 Feb;274(2):379-86. doi: 10.1148/radiol.14140313. Epub 2014 Oct 7.
6
Physiologically Based Pharmacokinetic Modeling of Transporter-Mediated Hepatic Disposition of Imaging Biomarker Gadoxetate in Rats.基于生理学的转运体介导的大鼠成像生物标志物钆塞酸在肝内处置的药代动力学模型。
Mol Pharm. 2021 Aug 2;18(8):2997-3009. doi: 10.1021/acs.molpharmaceut.1c00206. Epub 2021 Jul 20.
7
Value of gadoxetate biliary transit time in determining hepatocyte function.钆塞酸二钠胆汁转运时间在评估肝细胞功能中的价值。
Abdom Imaging. 2015 Jan;40(1):95-101. doi: 10.1007/s00261-014-0200-3.
8
Gadolinium-ethoxybenzyl-DTPA, a new liver-specific magnetic resonance contrast agent. Kinetic and enhancement patterns in normal and cholestatic rats.钆-乙氧基苄基-二乙三胺五乙酸,一种新型肝脏特异性磁共振造影剂。正常及胆汁淤积大鼠的动力学和增强模式。
Invest Radiol. 1992 Aug;27(8):612-9.
9
Assessment of gadoxetate DCE-MRI as a biomarker of hepatobiliary transporter inhibition.评估钆塞酸二钠 DCE-MRI 作为肝胆转运体抑制剂的生物标志物。
NMR Biomed. 2013 Oct;26(10):1258-70. doi: 10.1002/nbm.2946. Epub 2013 Apr 7.
10
Preclinical evaluation of Gd-EOB-DTPA as a contrast agent in MR imaging of the hepatobiliary system.钆塞酸二钠作为肝胆系统磁共振成像造影剂的临床前评估
Radiology. 1992 Apr;183(1):59-64. doi: 10.1148/radiology.183.1.1549695.